| Market Cap | 121.11M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -11.69M | Forward P/E | - | EPS next Y | -6.70% | 50D Avg Chg | -11.00% |
| Sales | 365k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -17.00% |
| Dividend | N/A | Price/Book | 50.49 | EPS next 5Y | - | 52W High Chg | -92.00% |
| Recommedations | - | Quick Ratio | 2.95 | Shares Outstanding | 31.70M | 52W Low Chg | 12.00% |
| Insider Own | 37.04% | ROA | -60.92% | Shares Float | 22.32M | Beta | - |
| Inst Own | 1.66% | ROE | -121.56% | Shares Shorted/Prior | 688.94K/342.89K | Price | 4.14 |
| Gross Margin | 100.00% | Profit Margin | - | Avg. Volume | 320,301 | Target Price | 6.00 |
| Oper. Margin | -4,076.02% | Earnings Date | - | Volume | 39,250 | Change | -3.50% |
Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024. Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.